CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 29 filers reported holding CASI PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q3 2015 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q1 2015 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q3 2014 | $0 | – | 45 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellington Shields Capital Management, LLC | 2,188,547 | $1,751,000 | 0.22% |
| Wellington Shields & Co., LLC | 1,141,190 | $913,000 | 0.18% |
| Ikarian Capital, LLC | 1,223,067 | $978,000 | 0.15% |
| Ground Swell Capital, LLC | 18,638 | $15,000 | 0.09% |
| Anson Funds Management LP | 267,507 | $214,000 | 0.02% |
| Sterneck Capital Management, LLC | 40,000 | $32,000 | 0.02% |
| FEDERATED HERMES, INC. | 10,150,000 | $8,120,000 | 0.02% |
| Roundview Capital LLC | 122,453 | $98,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,677,146 | $1,342,000 | 0.01% |
| RBF Capital, LLC | 159,367 | $127,000 | 0.01% |